Sun Pharma#39;s offer amounts to about $347.8 million, as per Reuters calculations, with the per share value at a 4.2% premium to Taro#39;s close on Wednesday.
Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 million on January 18, 2024 at 1:30 am
